Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Latent tuberculosis
Apr 10, 2020
Lilly Begins Clinical Testing of Therapies for COVID-19
Jan 31, 2020
Immunitor unveils breakthrough immunotherapy to treat tuberculosis in as short as one month
Aug 23, 2019
Lilly Announces Top-Line Phase 3 Results for Oral JAK Inhibitor Baricitinib, in Combination with Topical Corticosteroids in Adult Patients with Moderate to Severe Atopic Dermatitis
Jul 23, 2019
Global Latent Tuberculosis Infection Testing Market 2019-2023: Rising Prevalence of HIV and Increasing Government Initiatives to Drive Market Growth
Feb 04, 2019
Lilly Announces Top-Line Phase 3 Results for Baricitinib in Patients with Moderate to Severe Atopic Dermatitis
Oct 21, 2018
ACR 2018: Lilly Shares Updated Safety Analysis of OLUMIANT® (baricitinib) in Patients with Moderately-to-Severely Active Rheumatoid Arthritis
Oct 01, 2018
IAVI Acquires Aeras TB Vaccine Clinical Programs and Assets
Sep 25, 2018
Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec
Aug 24, 2018
Global Tuberculosis (TB) Drugs/Therapeutics Market, 2018-2025 - Key Players are J&J Services, Lupin, Pfizer, Novartis, Macleods Pharmaceuticals, and Otsuka Pharmaceutical
Jul 18, 2018
TB Drugs Market Size Worth $1.38 Billion by 2025 | CAGR: 5.2%: Grand View Research, Inc.
Jul 04, 2018
The global tuberculosis drugs/therapeutics (TB) market size is expected to reach USD 1.38 billion by 2025
Feb 19, 2018
Aeras Highlights Commitment to Eradicating the World's Leading Infectious Disease Killer at the 5th Global Forum on Tuberculosis
Feb 19, 2018
Results from Innovative Phase 2 Tuberculosis Vaccine Trial Offer Potential for New BCG Revaccination Strategies, Hope For Subunit Vaccines
Jan 08, 2018
QIAGEN and DiaSorin Partner to Offer Fully Automated Tuberculosis Detection With QuantiFERON-TB Gold Plus Available on LIAISON Analyzer Systems
Jul 26, 2017
Caprion Biosciences Expands Biomarker Panel Portfolio to Include Predictive Tuberculosis (TB) Infections
Jun 22, 2017
French health system approves reimbursement of QIAGEN's QuantiFERON latent TB test
Jun 08, 2017
QIAGEN's QuantiFERON®-TB Gold Plus gains U.S. FDA approval
Latest News
Apr 26, 2024
Leeward Renewable Energy Releases Inaugural Sustainability Highlights Report
Apr 26, 2024
Parsec’s Double Award Win Showcases Dedication to Customers and Manufacturing Expertise
Apr 25, 2024
FCA Packaging Invests in Greentree Packaging and Lumber
Apr 25, 2024
TriMas Packaging Receives Silver Award as Strategic Supplier
Apr 25, 2024
Effigis Geo-Solutions Inc. and Provincial Pole Specialists, Inc. Are Rebranded to Osmose Utilities Services...
Apr 25, 2024
Materion Corporation to Announce First Quarter 2024 Financial Results on May 1
Apr 25, 2024
Universal Robots announces seamless integration with Siemens PLCs
Apr 25, 2024
Stak Mobility to Launch Second Mobility Hub in Pittsburgh; Sees Continued Momentum Across the US
View all News
Agenda
24
September
Hilton London Syon Park, London, UK
Defence Transformation Conference
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
View All Events